Lushang Freda Pharmaceutical (SH:600223)2019-04-26 16:00Financial Performance - Operating revenue for the period was ¥947,620,692.81, representing a significant increase of 46.42% compared to the same period last year[11]. - Net profit attributable to shareholders of the listed company was ¥43,003,625.66, up 105.16% year-on-year[11]. - Basic earnings per share increased to ¥0.04, doubling from ¥0.02 in the previous year[11]. - The company's operating revenue for the current period reached CNY 1,387,543,607.51, an increase of CNY 439,922,914.70 or 46.42% compared to the previous period, primarily due to increased real estate project settlements[21]. - The net profit attributable to shareholders of the parent company was CNY 43,003,625.66, up CNY 22,042,586.32 or 105.16%, driven by increased real estate project settlements and profits from joint ventures[21]. - Operating profit for Q1 2019 was ¥111,563,034.62, compared to ¥44,589,149.65 in Q1 2018, reflecting a significant growth[51]. - Net profit for Q1 2019 was ¥51,537,467.32, up from ¥24,920,777.31 in Q1 2018, indicating a year-over-year increase of 106.5%[51]. Cash Flow - The net cash flow from operating activities was ¥436,742,766.38, a recovery from a negative cash flow of ¥689,978,855.98 in the same period last year[11]. - The net cash flow from operating activities was CNY 436,742,766.38, a significant improvement of CNY 1,126,721,622.36 compared to the previous period, mainly due to reduced land payments[21]. - The net cash flow from operating activities for Q1 2019 was ¥436,742,766.38, a recovery from a negative cash flow of -¥689,978,855.98 in Q1 2018[60]. - The total cash outflow from operating activities in Q1 2019 was 12,267,580.82 RMB, compared to 5,712,358.19 RMB in Q1 2018, indicating increased operational costs[63]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥50,067,503,801.32, an increase of 2.43% compared to the end of the previous year[11]. - Total liabilities as of March 31, 2019, reached ¥47,092,586,826.94, compared to ¥45,989,478,823.15 at the end of 2018, reflecting a rise of approximately 2.41%[39]. - The company's long-term borrowings increased to ¥6,457,811,240.44 from ¥5,885,697,679.39, which is an increase of approximately 9.70%[39]. - The total current liabilities increased to ¥40,551,782,029.95 from ¥40,020,523,209.33, indicating a rise of about 1.32%[39]. - Total liabilities decreased to ¥873,433,788.42 from ¥2,997,170,299.47, showing a reduction of approximately 70.8%[46]. Shareholder Information - Net assets attributable to shareholders of the listed company amounted to ¥2,481,958,609.62, reflecting a growth of 1.84% year-on-year[11]. - The total number of shareholders at the end of the reporting period was 28,174[12]. - The largest shareholder, Shandong Commercial Group Co., Ltd., held 530,722,779 shares, accounting for 53.02% of the total share capital[12]. Expenses and Costs - Operating costs amounted to CNY 991,791,474.59, reflecting an increase of CNY 317,035,637.27 or 46.99%, corresponding to the rise in revenue[21]. - Financial expenses increased to CNY 9,518,631.07, up CNY 3,165,374.73 or 49.82%, attributed to interest from completed projects being accounted for as period expenses[21]. - The company reported a decrease in other income to CNY 2,124,696.28, down CNY 5,578,604.71 or 72.42%, due to fewer government subsidies received compared to the previous period[21]. - The total cost of operations for Q1 2019 was ¥1,288,674,256.44, up from ¥910,792,332.57 in Q1 2018, representing a 41.4% increase[48]. Future Outlook - The company anticipates continued growth in operating profit, with a projected increase in net profit for the upcoming periods[21].